Other
Antiretroviral Treatment
0
Pipeline Programs↗
6
Active Trials↗
6
Companies Involved↗
Antiretroviral Treatment is an early-stage landscape with 0 programs across 6 companies. The most active players are Gilead, Johnson & Johnson, Tobira Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
49
clinical trials
Completed33 · 67%
Unknown status5 · 10%
Active, not recruiting3 · 6%
Terminated3 · 6%
Not yet recruiting2 · 4%
Withdrawn2 · 4%
Other1 · 2%
Clinical Trials
Trial Activity
49 trials
Pausing Antiretroviral Treatment Under Structured Evaluation
Active, not recruiting·AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections·Phase 1·NCT06031272·32 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)